MedPath
NMPA Approval

Sodium Hyaluronate Eye Drops

国药准字H20244590

July 30, 2024

Drug Information

玻璃酸钠滴眼液

眼用制剂

0.1%(5ml:5mg)

化学药品

July 30, 2024

Company Information

Applicant Company

山东省济宁市嘉祥县嘉祥大道1号

Manufacturing Company

山东省济宁市嘉祥县嘉祥大道1号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

玻璃酸钠滴眼液 - NMPA 批准文号 | MedPath